Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105

NCT05289726 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Hand and Foot Skin Reaction
Colorectal Cancer Stage IV

Interventions

DRUG: Traditional chinese medicine TDX105
DRUG: Placebo

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences